Identification of C6-ceramide-interacting proteins in D6P2T Schwannoma cells

Proteomics

Volumn 12, Issue 13, 2012, Pages 2179-2184

  Kota, Venkatesh ^a   Szulc, Zdzislaw M ^a   Hama, Hiroko ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cell biology; Cell signaling; Interaction profiling; Liquid chromatography tandem mass spectrometry

Indexed keywords

CARBON; CARBON 6; CERAMIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOGENESIS; CELL ACTIVATION; CELL CYCLE; CELL DIFFERENTIATION; CELL STRESS; CELL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; NEURILEMOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; TANDEM MASS SPECTROMETRY;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CERAMIDES; CHROMATOGRAPHY, LIQUID; NEURILEMMOMA; PROTEINS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 84864000096     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100527     Document Type: Article

References (22)

1. Ogretmen, B., Hannun, Y. A., Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 2004, 4, 604-616.
2. Struckhoff, A. P., Bittman, R., Burow, M. E., Clejan, S. et al., Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. J. Pharm. Exp. Ther. 2004, 309, 523-532.
3. Hannun, Y. A., Obeid, L. M., Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 2008, 9, 139-150.
4. Chalfant, C. E., Rathman, K., Pinkerman, R. L., Wood, R. E. et al., De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. J. Biol. Chem. 2002, 277, 12587-12595.
5. Perry, D. K., Carton, J., Shah, A. K., Meredith, F. et al., Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem. 2000, 275, 9078-9084.
6. Lucci, A., Han, T. Y., Liu, Y. Y., Giuliano, A. E., Cabot, M. C., Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. Int. J. Oncol. 1999, 15, 541-546.
7. Radin, N. S., Killing tumours by ceramide-induced apoptosis: a critique of available drugs. Biochem. J. 2003, 371, 243-256.
8. Senchenkov, A., Litvak, D. A., Cabot, M. C., Targeting ceramide metabolism-a strategy for overcoming drug resistance. J. Natl. Cancer Inst. 2001, 93, 347-357.
9. Strum, J. C., Small, G. W., Pauig, S. B., Daniel, L. W., 1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. J. Biol. Chem. 1994, 269, 15493-15497.
10. Lemonnier, L. A., Dillehay, D. L., Vespremi, M. J., Abrams, J. et al., Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch. Biochem. Biophys. 2003, 419, 129-138.
11. Huang, W. C., Chen, C. L., Lin, Y. S., Lin, C. F., Apoptotic sphingolipid ceramide in cancer therapy. J. Lipids 2011, 2011, 565316.
12. Hannun, Y. A., Sphingolipid second messengers: tumor suppressor lipids. Adv. Exp. Med. Biol. 1997, 400A, 305-312.
13. Stover, T. C., Sharma, A., Robertson, G. P., Kester, M., Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin. Cancer Res. 2005, 11, 3465-3474.
14. Huwiler, A., Brunner, J., Hummel, R., Vervoordeldonk, M. et al., Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. USA 1996, 93, 6959-6963.
15. Zhang, Y., Yao, B., Delikat, S., Bayoumy, S. et al., Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997, 89, 63-72.
16. Abbott, D. E., Margaryan, N. V., Jeruss, J., Khan, S. et al., Reevaluating Cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol. Ther. 2010, 9, 23-30.
17. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O. et al., Cathepsin D. protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 1996, 15, 3861-3870.
18. Bourbon, N. A., Yun, J., Kester, M., Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J. Biol. Chem. 2000, 275, 35617-35623.
19. Hanada, K., Kumagai, K., Yasuda, S., Miura, Y. et al., Molecular machinery for non-vesicular trafficking of ceramide. Nature 2003, 426, 803-809.
20. Mukhopadhyay, A., Saddoughi, S. A., Song, P., Sultan, I. et al., Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling. FASEB J. 2009, 23, 751-763.
21. Ong, D. E., Brady, R. N., Synthesis of ceramides using N-hydroxysuccinimide esters. J. Lipid Res. 1972, 13, 819-822.
22. Ruvolo, P. P., Gao, F., Blalock, W. L., Deng, X. et al., Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX. J. Biol. Chem. 2001, 276, 11754-11758.